Screening & Management of Anal Dysplasia in the HIV Clinic
Training slides cover why people with HIV (PWH) are at higher risk for anal dysplasia and cancer, and review recommended anal cancer screening methods...
Training slides cover why people with HIV (PWH) are at higher risk for anal dysplasia and cancer, and review recommended anal cancer screening methods...
Training slides summarize the current epidemiology of anal cancer risk in different high-risk populations and the sensitivity and specificity of cytol...
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment. The AETC Natio...
Training slides learning objectives include:
The purpose of this resource is to increase clinician awareness of the increased prevalence of specific illnesses and mortalities among people with HI...
The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention. The 37 les...
Training slides cover the risk and risk factors for lung cancer, primary and secondary prevention approaches, and tailoring smoking cessation and scre...
Training slides review
These slides provide updates from the CROI Conference, on anal cancer screening strategies, metabolic complications of HIV, as well as updates in hepa...
A key study from 2022, the ANCHOR Study, proved that treatment of high-grade precursors to anal cancer can prevent the development of anal cancer in people with HIV (PWH).
Rates of anal cancer are substantially higher in PWH (both women and men) than in people without HIV. In a process analogous to...